Pioglitazone Hydrochloride Tablet
Product Images NDC 70518-4519

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 70518-4519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Pioglitazone tablets in 45 mg strength with a quantity of 90 tablets. The tablets are round, white, and have an NDC number of 70518-4519-00. The manufacturer is Aurobindo based in Magar, India. The usual dosage instructions can be found in the insert provided. The tablets are repackaged by Remedy Repack Inc. in Indiana, PA. The medication should be kept out of reach of children and stored at 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F) as per USP standards.*
FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
This is a figure showing the mean change from baseline for HbA1c in a 26-week placebo-controlled dose-ranging study. The study tracked the observed values over the course of the weeks, comparing different dosages including 15mg, 30mg, and 45mg. The graph illustrates the changes in HbA1c levels throughout the study period.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.